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Background
The use of antimicrobials is the main cause for develop-
ment of antimicrobial resistance. Many countries
increasingly implement actions to control antimicrobial
resistance through rational use. The information on
national and local antimicrobial consumption can be an
important source for planning rational use interventions
and for monitoring progress towards a more prudent
use of antibiotics. In Romania, the particularities of
national antimicrobial consumption were never analyzed
before 2012. We aimed to identify specific features of
national antimicrobial consumption in Romania, and to
calculate the quality indicators for community antibiotic
usage.
Methods
We performed an analysis of national antibiotics sales
for 2012, provided by IMS Health Romania, a marketing
research company using ATC classification; the con-
sumption was measured in defined daily doses (DDD)/
1000 inhabitants/day. Data were split into hospital sales
and community sales. In order to evaluate the misuse of
antibiotics, we calculated the values for the 12 European
quality indicators of community usage of antibiotics as
defined during the European Surveillance of Antimicro-
bial Consumption (ESAC) project.
Results
Total consumption of antibacterials was 31.94 DDD/
1000inh/d (third place in Europe in 2011). In commu-
nity, the use of penicillins, cephalosporins, quinolones
and sulfonamides exceeded the median for EU member
states 1.78 to 2.46-fold; conversely, the use of tetracyclines,
nitrofurantoin, fosfomycin was below the European level
for these narrow spectrum antibiotics, 0.61-0.65-fold. The
indicators place Romania in the latest positions of quality
prescription in community (abuse and broader spectrum
antibiotics used 8.14-fold more than narrow spectrum
antibiotics). From community sales, 0.61 DDD/1000inh/d
were parenteral antibiotics, more than one fourth of anti-
biotic consumption in hospitals, 2.18 DDD/1000inh/d.
This level could place Romania in the fourth place among
the 18 European states communicating hospital consump-
tion for 2011; the most used antibiotics in hospital were
penicillins, 0.86 DDD/1000inh/d, aminoglycosides,
0.44DDD/1000inh/d and cephalosporins, 0.40 DDD/
1000inh/d.
Conclusion
Our analysis indicates several issues: high level of con-
sumption (abuse); low quality of antibiotic prescription
with unnecessary consumption of broad spectrum anti-
biotics instead of narrow spectrum antibiotics (misuse);
chaotic usage of antibiotics: parenteral treatments in
community in the absence of outpatient parenteral anti-
biotic medical teams and oral therapy in unnecessary
hospitalized patients. There is an urgent need to enhance
the people education about risk of antibiotics, to enforce
the legislation on antimicrobial sales, and to increase the
quality of medical education for rational prescribing of
antibiotics in the community and in hospitals (antimicro-
bial stewardship).
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